Section [Number]: Establishment of the [Name of Agency]: "There is hereby established within the Health and Human Services Administration (HHA) a designated agency to be known as the [Name of Agency], which shall be responsible for conducting analyses of the long-term healthcare costs associated with diseases and the potential savings resulting from cures."
Section [Number]: Determination of Long-Term Cost Savings: "The [Name of Agency] shall develop a standardized methodology for calculating the projected long-term healthcare costs for individuals with specific diseases and the potential cost savings achievable through the implementation of a cure."
Section [Number]: Mandatory Reimbursement for Cures: "Upon approval by the [Relevant Regulatory Body] of a therapy meeting the definition of a cure as outlined in Section [Reference Definition Section], insurance providers, including private insurers and public programs such as Medicare and Medicaid, shall be required to reimburse the developing pharmaceutical company a percentage, to be determined by the legislature, of the projected long-term cost savings as determined by the [Name of Agency]."
Section [Number]: Definition of Cure: "'Cure' shall mean a therapy that results in [insert specific criteria, e.g., sustained remission of [disease] for a period of [timeframe], eradication of [disease], or a significant and sustained improvement in health outcomes such that ongoing treatment for [disease] is no longer required]."